COST-EFFECTIVENESS ANALYSIS OF DULAGLUTIDE COMPARED WITH INSULIN GLARGINE ADD ON TO INSULIN LISPRO IN TREATMENT OF TYPE 2 DIABETES- A US THIRD-PARTY PAYER PERSPECTIVE
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1302
https://www.valueinhealthjournal.com/article/S1098-3015(16)01370-X/fulltext
Title :
COST-EFFECTIVENESS ANALYSIS OF DULAGLUTIDE COMPARED WITH INSULIN GLARGINE ADD ON TO INSULIN LISPRO IN TREATMENT OF TYPE 2 DIABETES- A US THIRD-PARTY PAYER PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01370-X&doi=10.1016/j.jval.2016.03.1302
First page :
A203
Section Title :
Diabetes/Endocrine Disorders - Cost Studies
Open access? :
No
Section Order :
641